Study of INT230-6 injection for soft tissue sarcoma
Treatments studied
Part of Cancer clinical trials.
This study tests an experimental drug, INT230-6, injected directly into tumors, compared to the usual treatments for soft tissue sarcoma. It aims to see if the injection is safe and works better for people whose cancer has not responded to earlier treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a type of soft tissue sarcoma, such as liposarcoma, leiomyosarcoma, or undifferentiated pleomorphic sarcoma, that cannot be removed with surgery.
- You have had at least one prior treatment for the sarcoma, and it has spread or grown despite that treatment.
- You have at least one tumor that is 2 centimeters or larger and can be safely injected with a needle, guided by imaging.
- You are in reasonably good health, with adequate kidney, liver, and blood counts.
- You are not pregnant, and if you can have children, you agree to use effective birth control.
- You have not had more than two prior treatments for advanced sarcoma.
- You do not have brain tumors that are unstable, or other cancers (except cured skin or bladder cancer).
- You are not taking blood thinners, aspirin, or strong interacting medications unless they can be stopped.
- You have not had radiation therapy within the last 2 weeks, or chemotherapy within the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests trabectedin plus ipilimumab and nivolumab in people with advanced soft-tissue sarcoma that has already been treated. It aims to see how well this combination works and how safely it can be given.
This trial is testing a new type of radiation therapy for advanced soft tissue sarcoma that has not responded to other treatments. The goal is to see if this therapy can shrink tumors and help control the cancer.
This trial tests whether a medicine injected directly into a tumor can shrink or control advanced soft tissue sarcoma. It mainly looks for people whose tumors can be safely injected with a hand exam or ultrasound.
This trial tests a new drug, HS-20093, combined with other treatments for people with advanced bone or soft tissue sarcoma. The goal is to see if these combinations can shrink tumors or slow their growth.
This trial tests an experimental drug, SOT106, that targets a specific marker on sarcoma cells. It aims to see if the drug is safe and effective in treating advanced osteosarcoma or soft tissue sarcoma when other treatments have not helped.
This study tests whether giving radiation, chemotherapy, and immunotherapy together can control high-risk soft tissue sarcoma that is hard to remove or may come back after surgery. It may help by attacking cancer in different ways, including boosting the immune system.
Hear when a new Sarcoma,Soft Tissue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.